BiotechTube

BAY 98-7079, Estradiolvalerate (EV) / Dienogest (DNG) / Levomefolate calcium + BAY 86-5027,Estradiolvalerate(EV) / Dienogest (DNG) + BAY 86-7660,levomefolate calcium

Phase 1Completed
0 watching 0 views this week💤 Quiet
30
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Pharmacology, Clinical

Conditions

Pharmacology, Clinical

Trial Timeline

Sep 1, 2009 → Jan 1, 2010

NCT ID
NCT00941057

About BAY 98-7079, Estradiolvalerate (EV) / Dienogest (DNG) / Levomefolate calcium + BAY 86-5027,Estradiolvalerate(EV) / Dienogest (DNG) + BAY 86-7660,levomefolate calcium

BAY 98-7079, Estradiolvalerate (EV) / Dienogest (DNG) / Levomefolate calcium + BAY 86-5027,Estradiolvalerate(EV) / Dienogest (DNG) + BAY 86-7660,levomefolate calcium is a phase 1 stage product being developed by Bayer for Pharmacology, Clinical. The current trial status is completed. This product is registered under clinical trial identifier NCT00941057. Target conditions include Pharmacology, Clinical.

Hype Score Breakdown

Clinical
10
Activity
5
Company
7
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT00941057Phase 1Completed

Competing Products

16 competing products in Pharmacology, Clinical

See all competitors
ProductCompanyStageHype Score
Fluconazole (BAYT006267) 150 mg capsules + Fluconazole 150 mg capsules (DiflucanTM)BayerPhase 1
30
Finerenone (BAY 94-8862) PEG solution + Finerenone (BAY 94-8862) immediate release tablet + Eplerenone (Inspra®) + PlaceboBayerPhase 1
30
Rivaroxaban (BAY 59-7939, Xarelto) in ODT form + Rivaroxaban (BAY 59-7939, Xarelto) in film-coated formBayerPhase 1
30
Naproxen sodium and diphenhydramine hydrochloride soft capsules + Naproxen sodium and diphenhydramine hydrochloride coated tablets (Aleve PM, BAY98-7111)BayerPhase 1
30
Nifedipine gastrointestinal therapeutic system (GITS) (Adalat LA, BAY a1040) + Candesartan cilexetilBayerPhase 1
30
Fosrenol ODT (Lanthanum Carbonate, BAY77-1931) + Fosrenol chewable Tablet (Lanthanum Carbonate, BAY77-1931)BayerPhase 1
30
Riociguat (Adempas, BAY63-2521) immediate release tablet of 2.5 mg + PlaceboBayerPhase 1
30
Neladenoson bialanate (BAY 1067197)BayerPhase 1
30
Riociguat (Adempas, BAY 63-2521)BayerPhase 1
30
Rivaroxaban (BAY 59-7939, Xarelto) in ODT form + Rivaroxaban (BAY 59-7939, Xarelto) in film-coated formBayerPhase 1
30
Loratadine + Pseudoephedrine sulfate (Claritin-D, BAY818725) (Manufacturer-SAG) + Loratadine + Pseudoephedrine sulfate (Claritin-D, BAY818725) (Manufacturer-Heist)BayerPhase 1
30
Riociguat (Adempas, BAY 63-2521)BayerPhase 1
30
Riociguat (BAY63-2521) + Riociguat (BAY63-2521) + Riociguat (BAY63-2521) + Riociguat (BAY63-2521) + Riociguat (BAY63-2521)BayerPhase 1
30
Loratadine + Pseudoephedrine sulfate (Claritin-D, BAY818725) (Manufacturer-SAG) + Loratadine + Pseudoephedrine sulfate (Claritin-D, BAY818725) (Manufacturer-Heist)BayerPhase 1
30
Neladenoson bialanate (BAY 1067197)BayerPhase 1
30
Aspirin (Acetylsalicylic acid, BAYe4465) + Aspirin (Acetylsalicylic acid, BAYe4465) + Aspirin (Acetylsalicylic acid, BAYe4465)BayerPhase 1
30

Other Products from Bayer

TelmisartanApproved
82
Clotrimazole vaginal tablet + FluconazoleApproved
82
Levitra (Vardenafil, BAY38-9456)Approved
82
Avelox (Moxifloxacin, BAY12-8039) + Amoxicillin clavulanic acidApproved
82
Rivaroxaban 20 MG + WarfarinApproved
82